Know the warning signs of Type 1 Diabetes. You could save a life.
Contents Summary Glycemic Index Individual foods Mixed meal or diet Glycemic Load Disease Prevention Type 2 diabetes mellitus Cardiovascular disease Cancer Gallbladder disease
Contents Summary Glycemic Index Individual foods Mixed meal or diet Glycemic Load Disease Prevention Type 2 diabetes mellitus Cardiovascular disease Cancer Gallbladder disease
Diabetes Poster - Does your child show any of these symptoms?
Obesity and diabetes are affecting the peoples of the Americas at high and increasing rates. National surveys demonstrate that obesity is increasing in prevalence among all age groups; 7% to 12% of children under 5 years old and
one-fi fth of adolescents are obese, while rates of overweight and obe...sity among adults approach 60%. Obesity is the major modifi able risk factor for diabetes.
more
Factors to take into account when choosing, reviewing and changing medicines.
Rescue therapy:
For symptomatic hyperglycaemia, consider insulin or a sulfonylurea and review when blood glucose control has been achieved.
Diet and lifestyle advice:
At each point reinforce advice about diet and life...style.
more
Lack of information about economic burden of COPD is a major cause of lack of attention to this chronic condition from governments and policymakers.
Chronic obstructive pulmonary disease (COPD) is an increasingly important cause of morbidity, disability, and mortality worldwide. We aimed to estimate global, regional, and national COPD prevalence and risk factors to guide policy and population interventions.
The document "Appropriate use and withdrawal of inhaled corticosteroids (ICS) in patients with chronic obstructive pulmonary disease (COPD)" from the IPCRG provides guidance on when to start, adjust, or discontinue ICS in COPD treatment. It highlights the benefits and risks, emphasizing personalized... treatment based on patient history, exacerbation frequency, and eosinophil count, while detailing how to optimize bronchodilator use to manage symptoms effectively.
more
The document is a visual guide created by the IPCRG for managing COPD, focusing on self-management, treatment options (such as inhaler use, pulmonary rehabilitation, and medications), and addressing comorbidities. It highlights the importance of personalized care plans, patient education, risk reduc...tion, vaccinations, and the correct use of therapies to improve quality of life and manage COPD effectively.
more
The International Primary Care Respiratory Group (IPCRG) is a clinically-led charitable company that works locally in primary care and collaborates globally to improve respiratory health. Our vision is that, through universal access to the right care, everyone can breathe and feel well.
The document "Chronic Respiratory Diseases: A Handbook for Pharmacists" outlines the significant role pharmacists play in managing asthma and COPD, emphasizing patient education, disease prevention, medication management, and promoting healthy lifestyles. It highlights the importance of pharmacists ...in supporting early detection, adherence to treatment, smoking cessation, and interprofessional collaboration to enhance respiratory care and outcomes.
more
The document outlines a comprehensive package of interventions for the rehabilitation of cardiopulmonary conditions, emphasizing assessments, treatments, and support mechanisms aimed at improving patients' quality of life and functional ability, provided by a multidisciplinary team.
The NICE guideline NG114 provides recommendations on antimicrobial therapy for acute exacerbations of chronic obstructive pulmonary disease (COPD), aiming to optimize antibiotic use and minimize the development of antibiotic resistance.
The document provides a summary of recommendations for the non-pharmacological management of chronic obstructive pulmonary disease (COPD) and the use of inhaled therapies in individuals over 16, emphasizing confirmed diagnosis, treatment options, and regular review of treatment effectiveness and inh...aler technique.
more
Chronic obstructive pulmonary disease (COPD) is a complex disease that requires differential diagnosis and proper classification to identify appropriate therapy. Nonpharmacologic therapy and preventative measures should be utilized to prevent worsening of disease, symptoms, and complications. The Gl...obal Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines classify a patient’s COPD and provide recommendations for first-line treatment. The 2021 update included information regarding the use of e-cigarettes as nicotine replacement, triple therapy, and how the SARS-CoV-2 virus impacted patients with COPD. This article will focus on the diagnosis, classification, and treatment of COPD, as well as recently updated information regarding the use of e-cigarettes and the impact of COVID-19.
more
The article provides a comprehensive overview of chronic obstructive pulmonary disease (COPD), covering its causes, symptoms, diagnostic methods, classification of severity, treatment options, and management strategies, with a focus on risk factors, clinical features, and therapeutic approaches such... as smoking cessation, bronchodilators, rehabilitation, and potential surgical interventions.
more
Silicosis is not a new disease; the impact of silica dust on respiratory function was observed by Hippocrates in 430 B.C. and in the 16th century by Agricol. In 1713, Rammazini described silicotic nodules in post-mortems of stone cutters presenting with respiratory symptoms. In the mid-late 1800s,... the introduction of mechanized tools in the mining sector rapidly increased levels of silica exposure, resulting in an increase in cases and our understanding of silicosis.
more
Die Grafik zur deutschen Entwicklungszusammenarbeit zeigt die Entwicklung der finanziellen Mittel Deutschlands im Zeitraum von 2014 bis 2024. Die absoluten Summen werden als Balken und in Eurobeträgen in Millionen dargestellt, während die Kurvenlinien die entsprechenden Prozentwerte im Verhältnis... zum deutschen Bruttonationaleinkommen (BNE) anzeigen. Das international vereinbarte Ziel für Entwicklungszusammenarbeit liegt bei 0,7 % des BNE und ist als gerade Linie im Diagramm eingefügt. Zudem empfiehlt die Weltgesundheitsorganisation (WHO), dass 0,1 % des BNE für gesundheitsbezogene Entwicklungszusammenarbeit bereitgestellt werden sollten.
Deutschland hat das 0,7%-Ziel bisher in keinem Jahr erreicht, wenn nur die realen Transferleistungen in die Betrachtung einbezogen werden. Die 0,1%-Empfehlung der WHO wurde lediglich im Jahr 2021 überschritten, was auf verstärkte Maßnahmen der Krisenreaktion zur Bewältigung der Covid-19-Pandemie zurückzuführen ist. In den Jahren 2020 und 2022 wurde die 0,1%-Empfehlung nahezu erreicht, blieb jedoch in den übrigen Jahren des betrachteten Zeitraums deutlich unerfüllt.
more